Expertise in
43
conditions

Dr. Michael F. Husak

Hematology Oncology | Hematology | Oncology
Lakeview Medical Center Inc Of Rice Lake
1700 W Stout St, 
Rice Lake, WI 
Accepting New Patients
43 Years of Experience
Expertise in
43
conditions
Lakeview Medical Center Inc Of Rice Lake
1700 W Stout St, 
Rice Lake, WI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Husak is a Hematologist Oncology specialist and a Hematologist in Rice Lake, Wisconsin. Dr. Husak has been practicing medicine for over 43 years is highly rated in 43 conditions, according to our data. His top areas of expertise are Familial Colorectal Cancer, Anal Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration. Dr. Husak is currently accepting new patients.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
1982
Specialties
Hematology Oncology
Hematology
Oncology
Licenses
Internal Medicine in WI
Hospital Affiliations
Marshfield Medical Center - Rice Lake
Marshfield Medical Center - Eau Claire
Marshfield Medical Center - Ladysmith
Languages Spoken
English
German
Italian
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
HealthPartners
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

LAKEVIEW MEDICAL CENTER INC OF RICE LAKE
1700 W Stout St, Rice Lake, WI 54868

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase II Randomized Study of Adjuvant Versus NeoAdjuvant Pembrolizumab (MK-3475) for Clinically Detectable Stage III-IV High-Risk Melanoma
A Phase II Randomized Study of Adjuvant Versus NeoAdjuvant Pembrolizumab (MK-3475) for Clinically Detectable Stage III-IV High-Risk Melanoma
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Procedure, Biological
Study Drug: Pembrolizumab
Study Phase: Phase 2
A Randomized Phase III Study of Immune Checkpoint Inhibition With Chemotherapy in Treatment-Naive Metastatic Anal Cancer Patients
A Randomized Phase III Study of Immune Checkpoint Inhibition With Chemotherapy in Treatment-Naive Metastatic Anal Cancer Patients
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Biological, Drug
Study Drugs: Carboplatin, Nivolumab, Paclitaxel
Study Phase: Phase 3
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 15, 2025
Intervention Type: Other, Procedure, Drug
Study Drugs: Entinostat, Exemestane, Goserelin, Goserelin Acetate
Study Phase: Phase 3
Randomized Phase II/III Study of Venetoclax (ABT199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas
Randomized Phase II/III Study of Venetoclax (ABT199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas
Enrollment Status: Active_not_recruiting
Publish Date: September 03, 2025
Intervention Type: Drug, Biological, Procedure
Study Drugs: Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide, Prednisone, Rituximab, Venetoclax, Vincristine Sulfate
Study Phase: Phase 2/Phase 3
Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 03, 2025
Intervention Type: Procedure, Drug, Biological
Study Drugs: Gemcitabine Hydrochloride, Pembrolizumab
Study Phase: Phase 2
A Randomized Phase II Trial of Carboplatin-Paclitaxel With or Without Ramucirumab in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma
A Randomized Phase II Trial of Carboplatin-Paclitaxel With or Without Ramucirumab in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma
Enrollment Status: Completed
Publish Date: March 25, 2025
Intervention Type: Drug, Biological
Study Drugs: Carboplatin, Paclitaxel, Ramucirumab
Study Phase: Phase 2
Phase III Placebo-Controlled Trial to Evaluate Dexamethasone Use for Everolimus-Induced Oral Stomatitis: Prevention Versus Early Treatment Approaches: MIST (My Individualized Stomatitis Treatment)
Phase III Placebo-Controlled Trial to Evaluate Dexamethasone Use for Everolimus-Induced Oral Stomatitis: Prevention Versus Early Treatment Approaches: MIST (My Individualized Stomatitis Treatment)
Enrollment Status: Terminated
Publish Date: January 29, 2025
Intervention Type: Other, Drug
Study Phase: Phase 3
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Enrollment Status: Active_not_recruiting
Publish Date: November 06, 2024
Intervention Type: Other, Drug, Radiation
Study Drugs: Cisplatin, Fluorouracil, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
View 7 Less Clinical Trials

2 Total Publications

Severe Thrombocytopenia Secondary to Babesiosis: A Case Report.
Severe Thrombocytopenia Secondary to Babesiosis: A Case Report.
Journal: Case reports in hematology
Published: February 14, 2024
Similar Doctors
Expertise in
34
conditions
Dr. Kareem H. Abdelhadi
Hematology Oncology | Hematology | Oncology
Expertise in
34
conditions
Dr. Kareem H. Abdelhadi
Hematology Oncology | Hematology | Oncology

Lakeview Medical Center Inc Of Rice Lake

1700 W Stout St, 
Rice Lake, WI 
 (0.1 miles away)
715-236-6133
Languages Spoken:
English, Arabic
See accepted insurances
Accepting New Patients

Kareem Abdelhadi is a Hematologist Oncology specialist and a Hematologist in Rice Lake, Wisconsin. Dr. Abdelhadi is highly rated in 34 conditions, according to our data. His top areas of expertise are Inflammatory Breast Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Colorectal Cancer. Dr. Abdelhadi is currently accepting new patients.

Expertise in
19
conditions
Dr. Timothy F. Burns
Oncology | Hematology | Hematology Oncology
Expertise in
19
conditions
Dr. Timothy F. Burns
Oncology | Hematology | Hematology Oncology

Mayo Clinic Health System-Northwest Wisconsin Region Inc

1400 Bellinger St, 
Eau Claire, WI 
 (49.4 miles away)
715-838-5222
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Timothy Burns is an Oncologist and a Hematologist in Eau Claire, Wisconsin. Dr. Burns is highly rated in 19 conditions, according to our data. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and EGFR Positive Lung Cancer. Dr. Burns is currently accepting new patients.

Expertise in
72
conditions
Dr. Sandeep K. Basu
Oncology | Hematology Oncology | Hematology
Expertise in
72
conditions
Dr. Sandeep K. Basu
Oncology | Hematology Oncology | Hematology

Mayo Clinic Health System-Northwest Wisconsin Region Inc

1400 Bellinger St, 
Eau Claire, WI 
 (49.4 miles away)
715-838-5222
Languages Spoken:
English, Bengali, Hindi, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Sandeep Basu is an Oncologist and a Hematologist Oncology provider in Eau Claire, Wisconsin. Dr. Basu is highly rated in 72 conditions, according to our data. His top areas of expertise are Gastric Lymphoma, Non-Hodgkin Lymphoma, Familial Colorectal Cancer, Colorectal Cancer, and Bone Marrow Aspiration. Dr. Basu is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Husak's expertise for a condition
ConditionClose
    View All 38 Advanced Conditions
    View All 111 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile